Cargando…
Humanized tau antibodies promote tau uptake by human microglia without any increase of inflammation
Immunotherapies targeting pathological tau have recently emerged as a promising approach for treatment of neurodegenerative disorders. We have previously showed that the mouse antibody DC8E8 discriminates between healthy and pathological tau, reduces tau pathology in murine tauopathy models and inhi...
Autores principales: | Zilkova, Monika, Nolle, Anna, Kovacech, Branislav, Kontsekova, Eva, Weisova, Petronela, Filipcik, Peter, Skrabana, Rostislav, Prcina, Michal, Hromadka, Tomas, Cehlar, Ondrej, Rolkova, Gabriela Paulikova, Maderova, Denisa, Novak, Michal, Zilka, Norbert, Hoozemans, Jeroen J. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7257136/ https://www.ncbi.nlm.nih.gov/pubmed/32471486 http://dx.doi.org/10.1186/s40478-020-00948-z |
Ejemplares similares
-
Therapeutic antibody targeting microtubule-binding domain prevents neuronal internalization of extracellular tau via masking neuron surface proteoglycans
por: Weisová, Petronela, et al.
Publicado: (2019) -
Identification of structural determinants on tau protein essential for its pathological function: novel therapeutic target for tau immunotherapy in Alzheimer’s disease
por: Kontsekova, Eva, et al.
Publicado: (2014) -
First-in-man tau vaccine targeting structural determinants essential for pathological tau–tau interaction reduces tau oligomerisation and neurofibrillary degeneration in an Alzheimer’s disease model
por: Kontsekova, Eva, et al.
Publicado: (2014) -
Microglia display modest phagocytic capacity for extracellular tau oligomers
por: Majerova, Petra, et al.
Publicado: (2014) -
Monoclonal antibodies targeting two immunodominant epitopes on the Spike protein neutralize emerging SARS-CoV-2 variants of concern
por: Kovacech, Branislav, et al.
Publicado: (2022)